Eton Pharmaceuticals Q3 EPS $(0.02) Beats $(0.10) Estimate, Sales $7.03M Beat $6.26M Estimate
Portfolio Pulse from bharat@benzinga.com
Eton Pharmaceuticals reported Q3 earnings per share of $(0.02), beating the analyst consensus estimate of $(0.10) by 80%. This is an 83.33% increase over the same period last year. The company also reported quarterly sales of $7.03 million, beating the analyst consensus estimate of $6.26 million by 12.27%. This is a 118.33% increase over the same period last year.
November 09, 2023 | 9:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Eton Pharmaceuticals reported better than expected Q3 earnings and sales, which could positively impact the stock price.
Eton Pharmaceuticals reported Q3 earnings and sales that beat analyst estimates. This positive financial performance could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100